About this webinar:

The use of MDMA and classical psychedelics for therapeutic purposes has been the subject of increasing research and popular interest in recent years. Despite burgeoning publications in this space, important questions remain regarding efficacy, safety and ethics. This webinar will provide an overview of Associate Professor Gillinder Bedi's group's work on safety, ethics and methodology in research and clinical use of MDMA and psychedelic-assisted psychotherapy for the treatment of mental health conditions.

About the speaker:

A/Prof Gillinder Bedi is Head of Substance Use Research at Orygen and Principal Research Fellow/Associate Professor (Addiction and Youth Mental Health) at the Centre for Youth Mental Health at the University of Melbourne. She is also a clinical psychologist at headspace, treating young people with substance use problems and comorbid mental illness. Her research seeks to (a) understand substance use and substance use disorders (with a focus on youth), (b) develop new early interventions and treatments for problematic substance use in youth, and (c) safely leverage the potential therapeutic effects of substances like MDMA.